Song, Bolin
Yang, Kailin
Viswanathan, Vidya Sankar
Wang, Xiangxue http://orcid.org/0000-0003-3341-9871
Lee, Jonathan http://orcid.org/0000-0002-5955-5145
Stock, Sarah
Fu, Pingfu http://orcid.org/0000-0002-2334-5218
Lu, Cheng
Koyfman, Shlomo
Lewis, James S. Jr
Madabhushi, Anant http://orcid.org/0000-0002-5741-0399
Funding for this research was provided by:
Division of Cancer Prevention, National Cancer Institute (R01CA249992-01A1, R01CA202752-01A1, R01CA208236-01A1)
Article History
Received: 22 January 2023
Accepted: 23 May 2023
First Online: 2 June 2023
Competing interests
: A.M. is an equity holder in Elucid Bioimaging and in Inspirata Inc. In addition, he has served as a scientific advisory board member for Inspirata Inc., AstraZeneca, Bristol Myers Squibb and Merck. Currently, he serves on the advisory board of Aiforia Inc. He also has sponsored research agreements with Philips, AstraZeneca, Boehringer-Ingelheim, and Bristol Myers Squibb. His technology has been licensed to Elucid Bioimaging. He is also involved in a NIH U24 grant with PathCore Inc., and 3 different R01 grants with Inspirata Inc. S.K. is a consultant for Merck and Regeneron, he has sponsored research agreements with Bristol Myers Squibb and Merck, and he receives honoraria from UpToDate. No potential conflicts of interest were disclosed by the other authors.